Simmons & Simmons has advised the majority shareholders of International Asset Management (IAM) on the sale of 100% of the company’s share capital to ABN Amro Asset Management. Corporate partners Alistair Bird and Stuart Evans led the Simmons team together with tax partner Nick Cronkshaw. Clifford Chance advised ABN Amro.
Morgan Cole’s southwest corporate finance partner Robert Cherry has acted for General Industries on its £27m reverse takeover of pharmaceutical research and development company ImmuPharma and a related £2.6m AIM placing. Bircham Dyson Bell company and commercial partner Peter McLoughlin and solicitor Shane O’Neill advised ImmuPharma. Lawrence Graham advised KBC Peel Hunt on the placing .
